A new laboratory to prevent inflammatory diseases associated with overweight and obesity.
Greentech, a world leader in plant biotechnology that produces ingredients for the cosmetics, pharmacy and nutrition sectors, recently teamed up with the ECREIN team of the Human Nutrition Unit at the Université Clermont Auvergne (UCA) and INRAE, known for its expertise in the study of immunocompetent cells.
These two partners have joined forces to create a joint public-private laboratory (Labcom) funded by the Agence Nationale de la Recherche (ANR). Called “Phytoprob’Inov” (phytoprobiotics, obesity, inflammation and innovation), the latter will develop new phytoprobiotics (plant and bacterial ingredients) for medical and cosmetic purposes that will target overweight and obesity associated with an inflammatory state, a major public health problem that currently does not have such a therapeutic response.
Phytoprob’Inov will be operational in the fall of 2020 and will mobilize about twenty people. It is part of the “mobility and health” component of the CAP 20-25 I-Site. This project, led by the UCA and a consortium of 20 partners (higher education and research, communities, companies, healthcare institutions, etc.), is one of the 18 initiatives of excellence recognized at the national level among dozens of applications, financed by the Forward Investment Programme II and implemented by the ANR.
Phone: 04.73.33.99.00 – Email: email@example.com